Clinical Trial

Multi-omics Study of Early-stage Lung Cancer With Distinct Phenotypes

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to investigate the multi-omics characterization early-stage lung cancer exhibiting distinct phenotypes including lung cancer associated with cystic airspaces, multiple primary lung cancers, and so on. The main questions it aims to answer are: * What are the differences in pathogenesis of non-small cell lung cancer with different phenotypes explored by multi-omics? * Whether differential genes lead to potential prognostic models and therapeutic targets? Participants will be followed up after surgery to answer prognosis: whether they have recurred, and the time to recurrence.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-05-31 -> 2026-12-31 2026-07-08
Trial Details
NCT Number NCT06699979
Lead Sponsor Central South University
Conditions Lung Cancer Associated With Cystic Airspaces, Multiple Primary Lung Cancers, Non-Small Cell Lung Cancer
Enrollment 300 participants
Start Date 2024-08-29
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-07